PAMELA WOHLGEMUTH: Open Payments
NPI 1326553272 · ROCKAWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 29 payments from 8 companies in 2025. Trend: 2023 $526 · 2024 $574 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $186 |
| E.R. Squibb & Sons, L.L.C. | 5 | $75 |
| PFIZER INC. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $18 |
Products named: VERQUVO, VYNDAQEL, JARDIANCE, ELIQUIS, CAMZYOS, AMVUTTRA, CAPVAXIVE, Kerendia.
Industry payments across NJ — which companies pay providers there.
